 Anna Helena Jonsson
Concepts (139)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Autoimmune Diseases | 3 | 2025 | 464 | 1.880 |
Why?
| | CD8-Positive T-Lymphocytes | 7 | 2025 | 949 | 1.490 |
Why?
| | Synovial Membrane | 9 | 2026 | 123 | 1.320 |
Why?
| | Arthritis, Rheumatoid | 10 | 2026 | 1171 | 1.280 |
Why?
| | Autoimmunity | 2 | 2025 | 927 | 1.130 |
Why?
| | Granzymes | 2 | 2025 | 50 | 1.040 |
Why?
| | Synovitis | 1 | 2023 | 33 | 0.800 |
Why?
| | T-Lymphocyte Subsets | 1 | 2025 | 422 | 0.770 |
Why?
| | B-Lymphocytes | 4 | 2025 | 890 | 0.460 |
Why?
| | Lymphocyte Activation | 3 | 2025 | 1143 | 0.380 |
Why?
| | Fibroblasts | 4 | 2026 | 1042 | 0.380 |
Why?
| | Chromosome Mapping | 2 | 2022 | 513 | 0.280 |
Why?
| | Single-Cell Analysis | 3 | 2024 | 363 | 0.250 |
Why?
| | CD47 Antigen | 1 | 2025 | 42 | 0.230 |
Why?
| | Arthritis, Juvenile | 1 | 2025 | 56 | 0.220 |
Why?
| | Adipocytes | 2 | 2024 | 221 | 0.220 |
Why?
| | Adalimumab | 1 | 2024 | 54 | 0.210 |
Why?
| | Receptors, Immunologic | 1 | 2025 | 208 | 0.210 |
Why?
| | Transcriptome | 3 | 2025 | 1060 | 0.210 |
Why?
| | Diabetes Mellitus, Type 2 | 4 | 2023 | 2599 | 0.210 |
Why?
| | Polymorphism, Single Nucleotide | 3 | 2023 | 2186 | 0.210 |
Why?
| | Th17 Cells | 1 | 2025 | 104 | 0.210 |
Why?
| | Quantitative Trait Loci | 2 | 2023 | 384 | 0.200 |
Why?
| | Immunophenotyping | 1 | 2025 | 327 | 0.200 |
Why?
| | Receptors, Glucocorticoid | 1 | 2024 | 139 | 0.200 |
Why?
| | Transforming Growth Factor beta | 1 | 2026 | 481 | 0.190 |
Why?
| | Genetic Variation | 2 | 2018 | 991 | 0.190 |
Why?
| | Hydrocortisone | 1 | 2024 | 307 | 0.180 |
Why?
| | Body Height | 1 | 2022 | 202 | 0.170 |
Why?
| | CD4-Positive T-Lymphocytes | 2 | 2025 | 1147 | 0.170 |
Why?
| | Antirheumatic Agents | 1 | 2024 | 303 | 0.170 |
Why?
| | Glucocorticoids | 1 | 2024 | 540 | 0.160 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 1 | 2022 | 335 | 0.160 |
Why?
| | Genome-Wide Association Study | 6 | 2023 | 1461 | 0.160 |
Why?
| | Chromatin | 1 | 2024 | 557 | 0.160 |
Why?
| | Humans | 21 | 2026 | 144857 | 0.150 |
Why?
| | Antigens, CD | 1 | 2022 | 564 | 0.150 |
Why?
| | Signal Transduction | 4 | 2026 | 5277 | 0.150 |
Why?
| | Genes, Mitochondrial | 1 | 2018 | 13 | 0.150 |
Why?
| | Metabolism | 1 | 2018 | 44 | 0.140 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2022 | 728 | 0.130 |
Why?
| | DNA, Mitochondrial | 1 | 2018 | 206 | 0.130 |
Why?
| | Transcription Factor 7-Like 2 Protein | 1 | 2017 | 26 | 0.130 |
Why?
| | Gene Expression Regulation | 2 | 2023 | 2633 | 0.120 |
Why?
| | Autoantibodies | 1 | 2023 | 1498 | 0.120 |
Why?
| | Receptor, Melatonin, MT2 | 1 | 2015 | 3 | 0.120 |
Why?
| | Hepatocyte Nuclear Factor 3-beta | 1 | 2015 | 12 | 0.120 |
Why?
| | Insulin | 4 | 2023 | 2511 | 0.110 |
Why?
| | Insulin Resistance | 1 | 2023 | 1255 | 0.110 |
Why?
| | Genetic Loci | 1 | 2015 | 275 | 0.100 |
Why?
| | Blood Glucose | 3 | 2023 | 2335 | 0.100 |
Why?
| | Cardiovascular Diseases | 2 | 2022 | 2108 | 0.100 |
Why?
| | Genetic Predisposition to Disease | 2 | 2023 | 2411 | 0.090 |
Why?
| | Mitochondria | 1 | 2018 | 988 | 0.090 |
Why?
| | Animals | 4 | 2026 | 38331 | 0.080 |
Why?
| | Glucose | 3 | 2023 | 1048 | 0.080 |
Why?
| | Biomarkers | 2 | 2022 | 4279 | 0.080 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2024 | 1225 | 0.080 |
Why?
| | Heart Failure | 1 | 2022 | 2181 | 0.070 |
Why?
| | Gene Expression Profiling | 2 | 2026 | 1829 | 0.070 |
Why?
| | Male | 8 | 2025 | 72189 | 0.060 |
Why?
| | Receptor, Notch3 | 1 | 2025 | 8 | 0.060 |
Why?
| | Glucose Tolerance Test | 2 | 2017 | 376 | 0.060 |
Why?
| | Chemokine CXCL13 | 1 | 2025 | 15 | 0.060 |
Why?
| | Receptors, CXCR3 | 1 | 2025 | 16 | 0.060 |
Why?
| | Receptors, CXCR5 | 1 | 2025 | 27 | 0.060 |
Why?
| | Longitudinal Studies | 2 | 2024 | 2971 | 0.060 |
Why?
| | Receptors, Transforming Growth Factor beta | 1 | 2026 | 57 | 0.060 |
Why?
| | Chemokine CXCL9 | 1 | 2025 | 38 | 0.060 |
Why?
| | Female | 8 | 2026 | 78217 | 0.060 |
Why?
| | Chemokine CXCL12 | 1 | 2025 | 89 | 0.060 |
Why?
| | Drug Resistance | 1 | 2026 | 154 | 0.060 |
Why?
| | Stromal Cells | 1 | 2025 | 129 | 0.060 |
Why?
| | Receptors, Notch | 1 | 2026 | 92 | 0.060 |
Why?
| | 11-beta-Hydroxysteroid Dehydrogenase Type 1 | 1 | 2024 | 10 | 0.060 |
Why?
| | Phenotype | 2 | 2023 | 3199 | 0.050 |
Why?
| | Adipogenesis | 1 | 2024 | 57 | 0.050 |
Why?
| | Lymphocyte Subsets | 1 | 2024 | 87 | 0.050 |
Why?
| | Transcription Factor AP-1 | 1 | 2024 | 79 | 0.050 |
Why?
| | Plasma Cells | 1 | 2024 | 75 | 0.050 |
Why?
| | Arthritis | 1 | 2024 | 96 | 0.050 |
Why?
| | Anti-Citrullinated Protein Antibodies | 1 | 2025 | 126 | 0.050 |
Why?
| | T-Box Domain Proteins | 1 | 2024 | 105 | 0.050 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2024 | 180 | 0.050 |
Why?
| | Interferons | 1 | 2024 | 193 | 0.050 |
Why?
| | Case-Control Studies | 2 | 2025 | 3628 | 0.050 |
Why?
| | Asialoglycoprotein Receptor | 1 | 2022 | 6 | 0.050 |
Why?
| | Colitis, Ulcerative | 1 | 2024 | 143 | 0.050 |
Why?
| | Rheumatoid Factor | 1 | 2024 | 175 | 0.050 |
Why?
| | Methotrexate | 1 | 2024 | 240 | 0.050 |
Why?
| | Antigens, Differentiation, Myelomonocytic | 1 | 2022 | 69 | 0.050 |
Why?
| | Sample Size | 1 | 2022 | 122 | 0.050 |
Why?
| | Complementarity Determining Regions | 1 | 2022 | 53 | 0.040 |
Why?
| | Linkage Disequilibrium | 1 | 2022 | 249 | 0.040 |
Why?
| | Europe | 1 | 2022 | 412 | 0.040 |
Why?
| | Gene Frequency | 1 | 2022 | 485 | 0.040 |
Why?
| | Haplotypes | 1 | 2022 | 491 | 0.040 |
Why?
| | Crohn Disease | 1 | 2024 | 256 | 0.040 |
Why?
| | Genome, Human | 1 | 2022 | 429 | 0.040 |
Why?
| | Cell Lineage | 1 | 2022 | 378 | 0.040 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2024 | 360 | 0.040 |
Why?
| | Aged | 3 | 2025 | 25822 | 0.040 |
Why?
| | Epigenesis, Genetic | 1 | 2024 | 687 | 0.040 |
Why?
| | Waist-Hip Ratio | 1 | 2018 | 37 | 0.040 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2022 | 392 | 0.040 |
Why?
| | Cell Proliferation | 1 | 2025 | 2543 | 0.030 |
Why?
| | Middle Aged | 3 | 2025 | 35939 | 0.030 |
Why?
| | Liver | 2 | 2017 | 1853 | 0.030 |
Why?
| | Macrophages | 1 | 2025 | 1532 | 0.030 |
Why?
| | Transcription, Genetic | 1 | 2024 | 1506 | 0.030 |
Why?
| | Mice, Knockout | 1 | 2024 | 3147 | 0.030 |
Why?
| | Genotyping Techniques | 1 | 2017 | 70 | 0.030 |
Why?
| | Adult | 3 | 2025 | 40438 | 0.030 |
Why?
| | Glucagon-Like Peptide 1 | 1 | 2017 | 146 | 0.030 |
Why?
| | Arginine | 1 | 2017 | 267 | 0.030 |
Why?
| | C-Peptide | 1 | 2017 | 188 | 0.030 |
Why?
| | Transcription Factors | 1 | 2024 | 1741 | 0.030 |
Why?
| | Peptides | 1 | 2022 | 1002 | 0.030 |
Why?
| | Cytokines | 1 | 2023 | 2100 | 0.030 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2015 | 140 | 0.030 |
Why?
| | Molecular Sequence Annotation | 1 | 2015 | 104 | 0.030 |
Why?
| | T-Lymphocytes | 1 | 2023 | 2045 | 0.030 |
Why?
| | Linear Models | 1 | 2017 | 860 | 0.030 |
Why?
| | Alleles | 1 | 2017 | 883 | 0.030 |
Why?
| | Mice, Inbred C57BL | 1 | 2024 | 6067 | 0.020 |
Why?
| | Insulin-Secreting Cells | 1 | 2017 | 391 | 0.020 |
Why?
| | Binding Sites | 1 | 2015 | 1314 | 0.020 |
Why?
| | Genotype | 1 | 2017 | 1841 | 0.020 |
Why?
| | Inflammation | 1 | 2023 | 2911 | 0.020 |
Why?
| | Child, Preschool | 1 | 2025 | 11740 | 0.020 |
Why?
| | Genomics | 1 | 2015 | 836 | 0.020 |
Why?
| | Body Mass Index | 1 | 2018 | 2448 | 0.020 |
Why?
| | Diabetes Mellitus | 1 | 2018 | 1089 | 0.020 |
Why?
| | Islets of Langerhans | 1 | 2015 | 835 | 0.020 |
Why?
| | Cohort Studies | 1 | 2018 | 5898 | 0.020 |
Why?
| | Mice | 1 | 2024 | 18549 | 0.020 |
Why?
| | Adolescent | 1 | 2025 | 22396 | 0.010 |
Why?
| | Child | 1 | 2025 | 22620 | 0.010 |
Why?
| | Risk Factors | 1 | 2017 | 10672 | 0.010 |
Why?
|
|
Jonsson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|